EPI-2010: Began Phase I study

EpiGenesis Pharmaceuticals Inc., Cranbury, N.J. Product: EPI-2010 Business: Autoimmune/Inflammation Therapeutic category: Antisense Target: Adenosine A1 receptor mRNA Description: Inhaled antisense o...